INSIGHTS ON DRUG DEVELOPMENT
-
Customized Release Through Dispersed Dosage Formats
Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.
-
R&D Excellence at Asymchem's UK Facility
Dave Henderson outlines R&D excellence at a UK facility, highlighting integrated labs, advanced experimentation, expert teams, and seamless progression from discovery through scale-up and manufacturing.
-
Transformative Innovation: Advancing Drug Development Using In Silico Modeling
Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.
-
An Unparalleled Window Into IBD Immune Response
Discover how Organ-Chips provide an unparalleled view into the human immune response to IBD and allow researchers to accurately model the intricacies of immune cell recruitment.
-
Development Of A Non-Standard Protein Therapeutic2/4/2026
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Patient-Centric Formulations In Pediatric Adherence11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques6/27/2025
Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.
-
Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody3/24/2025
Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.
-
Targeted Modalities Set Elevated Standards For Precision4/7/2026
Explore how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes.
DRUG DEVELOPMENT SOLUTIONS
-
Accelerate your path to market with integrated support to streamline processes, reduce delays, and deliver safe, user-friendly drug-delivery solutions.
-
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
A60 F Stereo Microscope
Optimize your productivity and production quality
The intuitive A60 F and A60 S stereo microscopes fulfill what you need – high sample throughput, optimum visibility of product details and components, and easy processing of subassemblies.
-
See 80% more of your sample with a 46 mm object field
-
Comfortable access your sample due to the 122 mm working distance
-
Easy handling, less refocusing and time saving with up to 13.6 mm depth of field and Leica FusionOptics technology
-
Enables large surface overview and detailed observation with a magnification range from 5x to 30x
-
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
We simplify pre-production workflows—for both upstream and downstream—by delivering fit-for-purpose process liquid and buffer preparation solutions that enable you to produce life-changing therapeutics and vaccines, faster.